chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Left arm is numb; Muscle spasm; Can't use her left arm and she's left handed; Can barely take a shower/When she washes dishes, dish will fall off on her hand; Weakness in her left arm; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Left arm is numb), MUSCLE SPASMS (Muscle spasm), HYPOKINESIA (Can't use her left arm and she's left handed), IMPAIRED WORK ABILITY (Can barely take a shower/When she washes dishes, dish will fall off on her hand) and MUSCULAR WEAKNESS (Weakness in her left arm) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On 15-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced HYPOAESTHESIA (Left arm is numb), MUSCLE SPASMS (Muscle spasm), HYPOKINESIA (Can't use her left arm and she's left handed), IMPAIRED WORK ABILITY (Can barely take a shower/When she washes dishes, dish will fall off on her hand) and MUSCULAR WEAKNESS (Weakness in her left arm). At the time of the report, HYPOAESTHESIA (Left arm is numb), MUSCLE SPASMS (Muscle spasm) and HYPOKINESIA (Can't use her left arm and she's left handed) was resolving and IMPAIRED WORK ABILITY (Can barely take a shower/When she washes dishes, dish will fall off on her hand) and MUSCULAR WEAKNESS (Weakness in her left arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment information was provided.
This spontaneous report was received from a pharmacist referring to a 66 year old female patient. The patient had no pertinent medical history, drug reactions or allergies. On 21-SEP-2018, the patient was vaccinated with PNEUMOVAX 23 lot number: R000579, expiration date: 09-SEP-2019, intramuscularly, in the right arm, for prophylaxis (strength and dosage schedule were not reported). On the same day, the patient was vaccinated intramuscularly also in the right arm with an unspecified influenza virus vaccine (strength, dosage schedule, indication, lot number and expiration date were not reported).     Later on 21-SEP-2018 (a few hours later), the patient experienced injection site pain, swelling, erythema and developed a fever of 102 °F and the patient self-medicated with ice and diphenhydramine (BENEDRYL) without relief; therefore, the patient was examined at the hospital emergency room and was provided unspecified medical treatment, but no laboratory tests were carried out. On an unspecified day in September 2018, the patient was discharge to home on oral cephalexin (KEFLEX). The outcome of injection site pain, injection site erythema, injection site swelling and fever was reported as not recovered. The reporter did not assess the relatedness of the aforementioned adverse events with PNEUMOVAX 23 and the unspecified influenza virus vaccine .
Pt. cont. to cry nonstop for 8 hours straight after imm for 2mo. well check.
Site effect of moderna vaccine; This spontaneous case was reported by a patient and describes the occurrence of ADVERSE DRUG REACTION (Site effect of moderna vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ADVERSE DRUG REACTION (Site effect of moderna vaccine). At the time of the report, ADVERSE DRUG REACTION (Site effect of moderna vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications was reported Treatment information was not provided   Reporter did not allow further contact
Swollen/swelling; pain; Fatigue aggravated/Felt a little more tired for the whole day; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue aggravated/Felt a little more tired for the whole day), SWELLING (Swollen/swelling) and PAIN (pain) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    It was unknown whether the patient was enrolled in a COVID-19 trial or not.  Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe Rheumatoid arthritis).   On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 17-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In May 2022, the patient experienced FATIGUE (Fatigue aggravated/Felt a little more tired for the whole day). On an unknown date, the patient experienced SWELLING (Swollen/swelling) and PAIN (pain). In May 2022, FATIGUE (Fatigue aggravated/Felt a little more tired for the whole day) had resolved. At the time of the report, SWELLING (Swollen/swelling) and PAIN (pain) had not resolved.            No concomitant medications were reported.  No treatment information was reported.  The patient received Humira as co-suspect (form : solution for injection in prefilled pen).  The causality assessed between the co-suspect Humira with the event felt a little more tired for the whole day was reported as probable, while the causality assessed between the suspect Moderna vaccine with the event felt a little more tired for the whole day was reported as possible.  The causality assessed between the co-suspect Humira with the events swelling and pain was reported as not related.  The reporter did not have the lot number information, because the packaging was discarded.
Erythema and swelling at site 9 days after injection-given Augmentin.
Same day as being vaccinated employee states tingling, hardness, burning, and bruising at site
Information has been received from a physician concerning a female patient who was vaccinated with a dose of PNEUMOVAX 23. Subsequently the patient experienced swelling at the injection site. The patient was treated with (KEFLEX), over the counter BENADRYL and ice. Subsequently, the patient recovered. No product quality complaint was involved. This is one of two reported from the dame source. Additional information has been requested.
1)-Pain at injection site for first 5 days; 2)- Periodic reoccurring bouts of nausea accompanied by fever, headache, fatigue,rash that looks like measles on my cheeks and nose, body ache and chills lasting 2-6 hours that began 2 hours after receiving the injection and it has not subsided and it has been 8 days; 3) -Periodic cognitive issues i.e., cant recall words, misplacing items i.e., put food items in cabinet instead of refrigerator, etc; 4)-swollen glands in back and front of neck.
No adverse event; Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose) and NO ADVERSE EVENT (No adverse event) in an 18-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     It was unknown if the patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On 09-Feb-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Feb-2023, the patient experienced WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (Adult patient received a pediatric dose of the Moderna COVID19 vaccine monovalent as a first dose).    Concomitant medication was not provided.   Treatment information was not provided.
I was two weeks early with labor starting. I had gestational hypertension. I had one elevated blood pressure; 15 minutes later - sustained response - 146/97 in the morning. My OB got an admission time for alter that evening. My blood pressure was perfectly fine the entire time. (110/80 the whole time I was in the hospital.) It took about 48 hours from induction to birth. They induced me on Monday evening and baby was born  11:00 pm on Wednesday was when baby was born. Neopristal (they gave me lactacted ringers of the IV fluid) and Oxytocin - I had an epidural and then I suffered a level three tear. Baby was healthy 7 lb 15 oz - he was born on weeks 39 and 0 days. In recovery at this time.  1st Pregnancy - and first full term pregnancy Estimated due date was 09/29/2021  Notes: Got flu vaccine right after baby was born - maybe 9/20/2021 I got the TDAP vaccine - I think I got that sometime in July 2021.
headache; sore arm; This is a spontaneous report from a contactable healthcare professional (patient). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on 05Jan2021 at SINGLE DOSE for COVID-19 immunization.  Medical history included mononucleosis. The patient's concomitant medications were not reported.  In Jan2021, the patient experienced headache and sore arm with unknown outcomes. The patient was asking if she can resume her treatment with amoxicillin as she was supposed to be taking antibiotics.   Information on the Lot/batch number has been requested.
I started with red hives.  Three hours later they turned in to bright red masses all over my chest and back.  Very itchy everywhere. By the next morning I had a red rash all over my whole body even my feet,hands and neck and face.  My fingers and toes swelled like hotdogs.  My skin felt like it was on fire it was literally hot to the touch but I didn't have a fever.  It also felt like I had a bad sunburn to touch.  I went to the Dr. and she prescribed Benadryl and Prednesone (sp?) Sorry I am not where the bottle is for correct spelling. It is now 10/05/2009 I have been on the sertoids since Friday and I am still having sypmtoms and I am still very itchy. It itches deep under my skin.  I don't have a visible rash anymore.
Patient presented to the ED and was subsequently hospitalized twice within 6 weeks of receiving COVID vaccination. Dates of service were 04/05/21 and 4/22/21.
High Fever, 103 for 48 hours, syncope, passed out twice during the first 24 hours.  Severe back pain.
I have a sore arm; Sunday evening injection site became raised red swollen with a hot feel to it; Sunday evening injection site became raised red swollen with a hot feel to it; Sunday evening injection site became raised red swollen with a hot feel to it/The area between my collar bone and shoulder is swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (I have a sore arm), VACCINATION SITE OEDEMA (Sunday evening injection site became raised red swollen with a hot feel to it), VACCINATION SITE ERYTHEMA (Sunday evening injection site became raised red swollen with a hot feel to it) and VACCINATION SITE SWELLING (Sunday evening injection site became raised red swollen with a hot feel to it/The area between my collar bone and shoulder is swollen) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013L20A, 013L20A and 013L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CAPTOPRIL, HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE + CAPTOPRIL), DICLOFENAC, LOSARTAN and THIAMAZOLE (METHIMAZOLE) for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (I have a sore arm), VACCINATION SITE OEDEMA (Sunday evening injection site became raised red swollen with a hot feel to it), VACCINATION SITE ERYTHEMA (Sunday evening injection site became raised red swollen with a hot feel to it) and VACCINATION SITE SWELLING (Sunday evening injection site became raised red swollen with a hot feel to it/The area between my collar bone and shoulder is swollen). At the time of the report, PAIN IN EXTREMITY (I have a sore arm), VACCINATION SITE OEDEMA (Sunday evening injection site became raised red swollen with a hot feel to it), VACCINATION SITE ERYTHEMA (Sunday evening injection site became raised red swollen with a hot feel to it) and VACCINATION SITE SWELLING (Sunday evening injection site became raised red swollen with a hot feel to it/The area between my collar bone and shoulder is swollen) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications was not specified No Medical History information was reported
headache; upset stomach; Extreme fatigue; Sleepiness; Sleepiness; This is a spontaneous report from a contactable consumer or other non HCP. This contactable consumer reported in response to non HCP letter sent which included.  A 56-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6206, Expiry date: unknown), via an unspecified route of administration, administered in Arm Right on 04Mar2021 (at the age of 56 years old) as dose 2, single for covid-19 immunisation at clinic and levothyroxine sodium (SYNTHROID, Batch/Lot number was not reported), via an unspecified route of administration from 1977 and ongoing. There is no relevant medical history. Concomitant medication(s) included sertraline hcl from 2010 and ongoing; omeprazole magnesium (PRILOSEC) from 2015 and ongoing. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3249, Expiry date: unknown), via an unspecified route of administration, administered in arm right on 06Feb2021 (at the age of 56 years old) as dose 1, single for covid-19 immunisation. No history of any previous immunization with the Pfizer vaccine considered as suspect. Adverse event did not require a visit to Emergency Room/Physician Office. No Adverse events following prior vaccinations. No relevant medical history (including any illness at time of vaccination). No relevant family medical history to adverse event. No relevant tests done. The patient experienced headache on 05Mar2021 08:00 & 06Mar2021, upset stomach on 05Mar2021 08:00, sleepiness day after vaccine on 05Mar2021, extreme fatigue on 05Mar2021 & 06Mar2021, sleepiness also on day 2 on 07Feb2021 08:00. The patient did not receive any treatment for the events. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are needed. No further information is expected.
This spontaneous report as received from a licensed practical nurse refers to a 2 year old patient of unknown gender. In November 2013 the patient was vaccinated with an adult dose of VAQTA, route and lot # unknown. There were no adverse effects reported. Additional information has been requested.
Within  72 hours fevers, body aches, myalgia, exhaustion, poor appetite.  Sx resolved after 7-10 days.
Pain at injection site, warm to touch, swollen and red. BENADRYL, cool compresses and MOTRIN. Fill ABx if worse.
This was the first dose of Quadracel for the patient, but 4th doses of DTaP and IPV. On 6/26/19, patient's mother reported the vaccination site reported red, swollen, non-tender, warm to touch, 4-5 in in circumference. The redness spread through following day of 6/27/19 and then started to resolve over the rest of the week. Patient given Benedryl.
Patient said he felt warm after the 1st dose  for 30  minutes.  He also said he had residual pain on the left arm after the 1st dose.   I offered to inject other arm, but he said he's right handed.     After the 2nd dose (4/21/21), patient said he felt warm again, but not as warm as before.  I offered him water, but he said no.  I suggested he go straight home to get some rest.   He had no visible sigh & symptoms of anaphylaxis.
I got COVID in December and my first period after was really heavy and long. My dad also passed away at the same time so it may be stress. Fast forward to April I get the shot and I get my period that day with spotting. I continue my period the next day being super heavy and lasted 7 days. I also had a bad fever and other symptoms from the vaccine.  Since then its been super heavy with big clots. I went to the doctor for it, and according to them they did an ultrasound. The existing fibroid had grown quite a bit and I also developed new one since my last ultrasound. They suggested that surgery would be a better solution to take care of the problem.
Information has been received on 02-JAN-2018 regarding a case in litigation from a lawyer concerning a patient of unknown age and gender. There was no information provided regarding the patient's concurrent conditions, medical history or concomitant medications. The patient's healthcare provider, recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 15-NOV-2014, a pharmacist at a pharmacy administered the ZOSTAVAX (lot number, expiration, dose and route unknown) to the patient. On or about 23-DEC-2016, the patient was treated by a healthcare provider at a physician's office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events is not recovered. The causality of the events is related. Additional information has been requested.
NauseaVomiting & Tachycardia Narrative:  Vomiting BP=118/81 HR=117 T=98.0 O2=98% RA
Initial case received from a consumer, who is also the patient, on 22 September 2009. A female patient with no reported medical history received a flu vaccine (manufacturer, lot number, and date of administration not reported) and subsequently developed GUILLAIN BARRE syndrome. Treatment included cortisone and per the patient she later developed cataracts and diabetes. No additional information was reported. Documents held by sender: None.
Thirty six hours post infection, fatigue, muscle aches, and fevers  Lasting almost 96 hours
V ARlVAX underwent a temperature excursion and was then administered; This spontaneous report has been received from a clinic administrator and refers to a 10-year-old patient. The patient's medical history, concurrent conditions, concomitant therapies, and drugs reactions or allergies were not reported.  On 18-JAN-2022, the patient was vaccinated with an improperly stored varicella virus vaccine live (oka/merck) (VARIVAX), 0.5 milliliter, lot U022732 has been verified to be a valid lot number for varicella virus vaccine live (oka/merck) with a n expiration date on 20-JUL-2023, administered as prophylaxis (formulation, strength, frequency, anatomical injection site and route of administration were not provided).   Administered dose of vaccine experienced temperature excursion of 12.0 degrees Fahrenheit (F) for 9 hours and 38 minutes. There was previous temperature excursions (9.7 degree Fahrenheit for 2 hours and 41 minutes; 10.8 degree Fahrenheit for 2 hours and 45 minutes; 10.6 degree Fahrenheit for 4 hours and 16 minutes; 11.1 degree Fahrenheit for 3 hours and 14 minutes; 10.9 degree Fahrenheit for 4 hours and 43 minutes; 10.8 degree Fahrenheit for 2 hours and 17 minutes; 18.3 degree Fahrenheit for 2 hours and 36 minutes; 18.7 degree Fahrenheit for 3 hours and 4 minutes; 12.4 degree Fahrenheit for 9 hours and 43 minutes; 17.4 degree Fahrenheit for 24 hours and 00 minutes; 19.9 degree Fahrenheit for 10 hours and 57 minutes. (product storage error).   This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2202USA006001: US-009507513-2202USA005934:
had the shingles shot, still got shingles; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 31-Aug-2022 Reporter's Comments: The reporter reported the case via interactive digital media. The reporter said that as with most shots the actual condition was usually better but no guarantee you would not get whatever.  The patient had the shingles shot and still got shingles but do believe patient had a much milder version. Additional Supportive Information: This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation were unknown at the time of reporting. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2022AMR126032:Same reporter